Natriuretic peptides for risk stratification of patients with valvular aortic stenosis

Circulation: Heart Failure

Volumn 8, Issue 2, 2015, Pages 373-380

  Parikh, Vishal ^a   Kim, Candice ^a   Siegel, Robert J ^b   Arsanjani, Reza ^b   Rader, Florian ^b  

^a Department of Medicine ^*  (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

aortic valve stenosis; natriuretic peptides; prognosis; ventricular remodeling

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AORTA VALVE STENOSIS; ARTICLE; DISEASE SEVERITY; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL MORTALITY; SYMPTOMATOLOGY; AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASE; BLOOD; HEART VENTRICLE PRESSURE; MORTALITY; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

AORTIC VALVE STENOSIS; ASYMPTOMATIC DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VENTRICULAR PRESSURE;

EID: 84937568088     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.114.001649     Document Type: Article

References (50)

1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2438-88.
2. Bergler-Klein J, Klaar U, Heger M, Rosenhek R, Mundigler G, Gabriel H, Binder T, Pacher R, Maurer G, Baumgartner H. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation. 2004;109:2302-2308. doi: 10.1161/01. CIR.0000126825.50903.18.
3. Rajani R, Rimington H, Chambers J. B-type natriuretic peptide and tissue doppler for predicting symptoms on treadmill exercise in apparently asymptomatic aortic stenosis. J Heart Valve Dis. 2009;18:565-571.
4. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol. 2007;50:2357-2368. doi: 10.1016/j.jacc.2007.09.021.
5. Katz M, Tarasoutchi F, Pesaro AE, Lopes RD, Spina GS, Vieira ML, Grinberg M. Natriuretic peptides and long-term mortality in patients with severe aortic stenosis. J Heart Valve Dis. 2012;21:331-336.
6. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167. doi: 10.1056/NEJMoa020233.
7. Fradley MG, Larson MG, Cheng S, McCabe E, Coglianese E, Shah RV, Levy D, Vasan RS, Wang TJ. Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). Am J Cardiol. 2011;108:1341-1345. doi: 10.1016/j. amjcard.2011.06.057.
8. Clavel MA, Malouf J, Michelena HI, Suri RM, Jaffe AS, Mahoney DW, Enriquez-Sarano M. B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival. J Am Coll Cardiol. 2014;63: 2016-2025. doi: 10.1016/j.jacc.2014.02.581.
9. Weber M, Hausen M, Arnold R, Nef H, Moellman H, Berkowitsch A, Elsaesser A, Brandt R, Mitrovic V, Hamm C. Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis. Heart. 2006;92:1639-1644. doi: 10.1136/hrt.2005.085506.
10. Lim P, Monin JL, Monchi M, Garot J, Pasquet A, Hittinger L, Vanoverschelde JL, Carayon A, Gueret P. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J. 2004;25:2048-2053. doi: 10.1016/j.ehj.2004.09.033.
11. Lancellotti P, Moonen M, Magne J, O'Connor K, Cosyns B, Attena E, Donal E, Pierard L. Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. Am J Cardiol. 2010;105:383-388. doi: 10.1016/j.amjcard.2009.09.043.
12. Nessmith MG, Fukuta H, Brucks S, Little WC. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Am J Cardiol. 2005;96:1445-1448. doi: 10.1016/j.amjcard.2005.06.092.
13. Antonini-Canterin F, Popescu BA, Popescu AC, Beladan CC, Korcova R, Piazza R, Cappelletti P, Rubin D, Cassin M, Faggiano P, Nicolosi GL. Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement. Int J Cardiol. 2008;128:406-412. doi: 10.1016/j. ijcard.2007.05.039.
14. Elhmidi Y, Bleiziffer S, Piazza N, Ruge H, Krane M, Deutsch MA, Hettich I, Voss B, Mazzitelli D, Lange R. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation. J Invasive Cardiol. 2013;25:38-44.
15. Iwahashi N, Nakatani S, Umemura S, Kimura K, Kitakaze M. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis. J Am Soc Echocardiogr. 2011;24:984-991. doi: 10.1016/j.echo.2011.03.012.
16. Orlowska-Baranowska E, Baranowski R, Greszata L, Stepinska J. Brain natriuretic peptide as a marker of left ventricular hypertrophy in patients with aortic stenosis. J Heart Valve Dis. 2008;17:598-605.
17. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, Hamm C. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol. 2004;94:740-745. doi: 10.1016/j. amjcard.2004.05.055.
18. Gerber IL, Legget ME, West TM, Richards AM, Stewart RA. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol. 2005;95:898-901. doi: 10.1016/j. amjcard.2004.11.053.
19. Cimadevilla C, Cueff C, Hekimian G, Dehoux M, Lepage L, Iung B, Duval X, Huart V, Tubach F, Vahanian A, Messika-Zeitoun D. Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study. Heart. 2013;99:461-467. doi: 10.1136/heartjnl-2012-303284.
20. Scolletta S, Carlucci F, Biagioli B, Marchetti L, Maccherini M, Carlucci G, Rosi F, Salvi M, Tabucchi A. NT-proBNP changes, oxidative stress, and energy status of hypertrophic myocardium following ischemia/reperfusion injury. Biomed Pharmacother. 2007;61:160-6.
21. Maréchaux S, Hattabi M, Juthier F, Neicu DV, Richardson M, Carpentier E, Bouabdallaoui N, Delelis F, Banfi C, Breyne J, Jude B, Asseman P, Vincentelli A, Le Tourneau T, Graux P, Pibarot P, Ennezat PV. Clinical and echocardiographic correlates of plasma B-type natriuretic peptide levels in patients with aortic valve stenosis and normal left ventricular ejection fraction. Echocardiography. 2011;28:695-702. doi: 10.1111/j.1540-8175.2011.01418.x.
22. Roca M, Magne J, Clin A, Popescu BA, Piérard LA, Lancellotti P. Impact of aortic stiffness on left ventricular function and B-type natriuretic peptide release in severe aortic stenosis. Eur J Echocardiogr. 2011;12:850-856. doi: 10.1093/ejechocard/jer120.
23. Vanderheyden M, Goethals M, Verstreken S, De Bruyne B, Muller K, Van Schuerbeeck E, Bartunek J. Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy. J Am Coll Cardiol. 2004;44:2349-2354. doi: 10.1016/j.jacc.2004.09.038.
24. Ben-Dor I, Minha S, Barbash IM, Aly O, Dvir D, Deksissa T, Okubagzi P, Torguson R, Lindsay J, Satler LF, Pichard AD, Waksman R. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis. Am J Cardiol. 2013;112:574-579. doi: 10.1016/j. amjcard.2013.04.023.
25. Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J. 2005;26:1023-1030. doi: 10.1093/eurheartj/ehi236.
26. Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, Tønnessen T. The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis-one year follow-up. Eur J Heart Fail. 2006;8:257-262. doi: 10.1016/j. ejheart.2005.08.004.
27. Song BG, Park YH, Kang GH, Chun WJ, Oh JH, Choi JO, Lee SC, Park SW, Oh JK, Sung KI, Park P, Jeon ES. Preoperative, postoperative and oneyear follow-up of N-terminal pro-B-type natriuretic peptide levels in volume overload of aortic regurgitation: comparison with pressure overload of aortic stenosis. Cardiology. 2010;116:286-291. doi: 10.1159/000318019.
28. Vianello A, Perlini S, Cappelli S, Palladini G, Epistolato MC, Della Latta D, Cerillo A, Berti S, Chiappino D, Tanganelli P, Glauber M, Mazzone A. A multimarker study of degenerative aortic valve disease: stenoinsufficiency shows more indices of bad prognosis. Cardiology. 2013;124: 126-137. doi: 10.1159/000346396.
29. Cemri M, Arslan U, Kocaman SA, Cengel A. Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis. J Postgrad Med. 2008;54:12-16.
30. Wu C, Yang YJ, Zhao XY, Zhang J, Huang J, Wei BQ, Sun HS, Wang W, Yan P. Clinical value of NT-proBNP in the diagnosis and analysis of correlation of NT-proBNP with clinical and echocardiographic findings in patients with aortic stenosis. Zhonghua Yi Xue Za Zhi. 2010;90:2233-2236.
31. Melina G, Angeloni E, Benedetto U, Refice S, Miceli A, Miele C, Ciavarella GM, Sinatra R. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement. J Heart Valve Dis. 2010;19:171-176.
32. Poulsen SH, Søgaard P, Nielsen-Kudsk JE, Egeblad H. Recovery of left ventricular systolic longitudinal strain after valve replacement in aortic stenosis and relation to natriuretic peptides. J Am Soc Echocardiogr. 2007;20:877-884. doi: 10.1016/j.echo.2006.11.020.
33. Pfister R, Wahlers T, Baer FM, Scherner M, Strauch J, Erdmann E. Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement. Clin Res Cardiol. 2010;99:301-307. doi: 10.1007/s00392-010-0118-x.
34. Wagner JA, Störk S, Weidemann F, Strotmann J, Fiedel C, Ertl G, Voelker W. Natriuretic peptides and myocardial oxygen supply-to-demand ratio in patients with aortic stenosis. Eur J Clin Invest. 2007;37:463-471. doi: 10.1111/j.1365-2362.2007.01810.x.
35. Bergler-Klein J, Mundigler G, Pibarot P, Burwash IG, Dumesnil JG, Blais C, Fuchs C, Mohty D, Beanlands RS, Hachicha Z, Walter-Publig N, Rader F, Baumgartner H. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation. 2007;115:2848-2855. doi: 10.1161/CIRCULATIONAHA.106.654210.
36. Kefer J, Beauloye C, Astarci P, Renkin J, Glineur D, Dekleermaeker A, Vanoverschelde JL. Usefulness of B-type natriuretic peptide to predict outcome of patients treated by transcatheter aortic valve implantation. Am J Cardiol. 2010;106:1782-1786. doi: 10.1016/j.amjcard.2010.07.051.
37. Pedrazzini GB, Masson S, Latini R, Klersy C, Rossi MG, Pasotti E, Faletra FF, Siclari F, Minervini F, Moccetti T, Auricchio A. Comparison of brain natriuretic peptide plasma levels versus logistic EuroSCORE in predicting in-hospital and late postoperative mortality in patients undergoing aortic valve replacement for symptomatic aortic stenosis. Am J Cardiol. 2008;102:749-754. doi: 10.1016/j.amjcard.2008.04.055.
38. Solberg OG, Ueland T, Wergeland R, Dahl CP, Aakhus S, Aukrust P, Gullestad L. High-sensitive troponin T and N-terminal-brain-natriureticpeptide predict outcome in symptomatic aortic stenosis. Scand Cardiovasc J. 2012;46:278-285. doi: 10.3109/14017431.2012.687836.
39. Raffa GM, Jackson V, Liska J, Eriksson MJ, Caidahl K, Eriksson P, Franco-Cereceda A. Endothelin-1 and brain natriuretic peptide plasma levels decrease after aortic surgery. J Heart Valve Dis. 2010;19:724-730.
40. Spargias K, Alexopoulos E, Thomopoulou S, Dimopoulos A, Manginas A, Pavlides G, Voudris V, Karatassakis G, Athanassopoulos G, Cokkinos DV. Effect of balloon valvuloplasty in patients with severe aortic stenosis on levels of N-terminal pro-B-type natriuretic peptide. Am J Cardiol. 2009;104:846-849. doi: 10.1016/j.amjcard.2009.05.013.
41. Gotzmann M, Hehen T, Germing A, Lindstaedt M, Yazar A, Laczkovics A, Mumme A, Mügge A, Bojara W. Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis. Heart. 2010;96:1102-1106. doi: 10.1136/hrt.2009.180661.
42. Kerr AJ, Raffel OC, Whalley GA, Zeng I, Stewart RA. Elevated B-type natriuretic peptide despite normal left ventricular function on rest and exercise stress echocardiography in mitral regurgitation. Eur Heart J. 2008;29:363-370. doi: 10.1093/eurheartj/ehm553.
43. Detaint D, Messika-Zeitoun D, Chen HH, Rossi A, Avierinos JF, Scott C, Burnett JC Jr, Enriquez-Sarano M. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation. Am J Cardiol. 2006;97:1029-1034. doi: 10.1016/j.amjcard.2005.10.061.
44. Gabriel RS, Kerr AJ, Sharma V, Zeng IS, Stewart RA. B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation. Heart. 2008;94:897-902. doi: 10.1136/hrt.2007.126508.
45. Pizarro R, Bazzino OO, Oberti PF, Falconi M, Achilli F, Arias A, Krauss JG, Cagide AM. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J Am Coll Cardiol. 2009;54:1099-1106. doi: 10.1016/j. jacc.2009.06.013.
46. Potocki M, Mair J, Weber M, Hamm C, Burkard T, Hiemetzberger R, Peters K, Jander N, Cron TA, Hess N, Hoffmann A, Gekeler H, Gohlke-Bärwolf C, Buser P, Mueller C. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation. Am J Cardiol. 2009;104:559-564. doi: 10.1016/j.amjcard.2009.04.023.
47. Yusoff R, Clayton N, Keevil B, Morris J, Ray S. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. Am J Cardiol. 2006;97:1498-1501. doi: 10.1016/j.amjcard.2005.11.085.
48. Detaint D, Messika-Zeitoun D, Avierinos JF, Scott C, Chen H, Burnett JC Jr, Enriquez-Sarano M. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation. 2005;111:2391-2397. doi: 10.1161/01.CIR.0000164269.80908.9D.
49. Bahlmann E, Gerdts E, Cramariuc D, Gohlke-Baerwolf C, Nienaber CA, Wachtell K, Seifert R, Chambers JB, Kuck KH, Ray S. Prognostic value of energy loss index in asymptomatic aortic stenosis. Circulation. 2013;127:1149-1156. doi: 10.1161/CIRCULATIONAHA.112.078857.
50. Greve AM, Dalsgaard M, Bang CN, Egstrup K, Rossebø AB, Boman K, Cramariuc D, Nienaber CA, Ray S, Gohlke-Baerwolf C, Okin PM, Devereux RB, Køber L, Wachtell K. Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). Am J Cardiol. 2014;114:751-756. doi: 10.1016/j.amjcard.2014.06.006.